SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: billkirn who wrote (4853)7/11/1998 3:40:00 AM
From: JOHN W.  Read Replies (1) | Respond to of 6136
 
I hope that those involved in the illegal manipulation of this company are prepared for the consequences. An investigation is almost complete of this fraudulent activity. I don't know what the outcome will be. Good luck to all honest investors.




To: billkirn who wrote (4853)7/11/1998 1:47:00 PM
From: Tom Nealon  Respond to of 6136
 
According to this months Scientific American 90% of HIV cases are in developing nations and 90% of the money on treatment is spent in developed countries. In Sub-saharan Africa (where an overwhelming majority of cases reside) the virus is still transmitted largely by unprotected sex but blood transfusions are an increasing problem. Approximately 25% of the 2.5 million units of blood administered in Africa are still not screened.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News